(Public, NASDAQ:CYAN)   Watch this stock  
Find more results for CYAN
+0.23 (6.58%)
Real-time:   9:30AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.80 - 3.80
52 week 3.32 - 5.56
Open 3.80
Vol / Avg. 307.00/894.00
Mkt cap 19.69M
P/E     -
Div/yield     -
EPS -0.89
Shares 5.67M
Beta 1.34
Inst. own 30%
Jun 21, 2017
Q4 2017 Cyanotech Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -4.59% -13.80%
Operating margin -2.27% -2.47%
EBITD margin - 2.34%
Return on average assets -4.62% -14.16%
Return on average equity -8.17% -22.36%
Employees 88 -
CDP Score - -


73-4460 Queen Kaahumanu Hwy Ste 102
KAILUA KONA, HI 96740-2637
United States - Map
+1-808-3261353 (Phone)
+1-808-3294533 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.

Officers and directors

Michael A. Davis M.D. Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Gerald R. Cysewski Ph.D. Interim President, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Jole Deal Chief Financial Officer, Vice President - Finance and Administration, Treasurer, Secretary
Age: 57
Bio & Compensation  - Reuters
Gerard J. Watts Chief Operating Officer
Age: 57
Bio & Compensation  - Reuters
James R. Lundeen Vice President,Senior Strategist
Age: 64
Bio & Compensation  - Reuters
Nancy E. Katz Director
Age: 56
Bio & Compensation  - Reuters
Walter B. Menzel Independent Director
Age: 69
Bio & Compensation  - Reuters
David M. Mulder Independent Director
Age: 55
Bio & Compensation  - Reuters
David L. Vied Independent Director
Age: 55
Bio & Compensation  - Reuters